R Clifford Jones

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
In a 2 year double blind controlled trial of cyclosporin against placebo in multiple sclerosis conducted at two centres there was a beneficial effect of the therapy upon the progression of the disease, relapse rate and relapse severity at one of the centres where the patients received a mean dose of 7.2 mg/kg/day. This beneficial effect was not seen in the(More)
  • 1